2P5A0129-square-webb

Anders Rylander

Anders Rylander
2P5A1413-square-webb

Annika Berg

Annika Berg
2P5A9880-square-webb

Henrik Osvald

Henrik Osvald
2P5A0138-square-webb

Jesper Söderqvist, Ph.D

Jesper Söderqvist, Ph.D
2P5A0168-square-webb

Lars Holmqvist

Lars Holmqvist
2P5A9973-square-webb

Maria Holmlund

Maria Holmlund
2P5A9824-square-webb

Marie-Louise Fjällskog, MD, Ph.D

Marie-Louise Fjällskog, MD, Ph.D
2P5A9812-square-webb

Ulf Jungnelius, MD

Ulf Jungnelius, MD

Board of Directors independence towards the Company

Biovica’s Board of Directors consists of eight ordinary members elected by the AGM, including the Chairman of the Board, who have been elected for the period until the next Annual General Meeting.

Position

Member since

Independent of Co. & Mgmt.

Ind. of Major Shareholders

Lars Holmqvist

  • Position

  • Chairman
  • Member since

  • 2019
  • Independent of Co. & Mgmt.

  • Yes
  • Ind. of Major Shareholders

  • Yes

Anders Rylander

  • Position

  • Board member, CEO
  • Member since

  • 2010
  • Independent of Co. & Mgmt.

  • No
  • Ind. of Major Shareholders

  • No

Marie-Louise Fjällskog

  • Position

  • Board Member
  • Member since

  • 2020
  • Independent of Co. & Mgmt.

  • Yes
  • Ind. of Major Shareholders

  • Yes

Maria Holmlund

  • Position

  • Board Member
  • Member since

  • 2016
  • Independent of Co. & Mgmt.

  • Yes
  • Ind. of Major Shareholders

  • Yes

Jarl Ulf Jungelius

  • Position

  • Board Member
  • Member since

  • 2014
  • Independent of Co. & Mgmt.

  • Yes
  • Ind. of Major Shareholders

  • Yes

Jesper Söderqvist

  • Position

  • Board Member
  • Member since

  • 2013
  • Independent of Co. & Mgmt.

  • Yes
  • Ind. of Major Shareholders

  • Yes

Henrik Osvald

  • Position

  • Board Member
  • Member since

  • 2019
  • Independent of Co. & Mgmt.

  • Yes
  • Ind. of Major Shareholders

  • Yes

Annika Carlsson Berg

  • Position

  • Board Member
  • Member since

  • 2020
  • Independent of Co. & Mgmt.

  • Yes
  • Ind. of Major Shareholders

  • Yes

Some of our Collaborations

>3200

Numbers of patients in studies

24

Publications

10

Pharma Contracts